Health Prediction Research with Hirosaki University and the Tokio Marine Group
First written in FY2022. 4 of 5 entries say "Advanced", first in FY2023. Latest entry: 2026-08-13.
1 other company's latest entry also says "Advanced".
- 2026-08-13AdvancedInvestor presentation
「Developed a disease-onset prediction model (four diseases), implemented it in the health screening results management system and began providing it Developed a health prediction model (test value prediction model), implemented it in the health screening results management system and began providing it」
The company reports concrete implementation results in its health and disease prediction research, moving from development to implementation and launch in the health screening results management system. - FY2025AdvancedAnnual report
「当連結会計年度の開発研究費の総額は54,545千円となっております。」
健康予測・疾病予防等に関する研究開発について、2025年12月期に54,545千円の開発研究費を計上した。 - FY2024AdvancedAnnual report
「疾病予測アプリ開発・健康予測シミュレーション開発に6,736千円等の投資を行いました。」
健康予測・疾病予測に関する研究開発について、2024年12月期にも具体的な投資を実施した。 - FY2023AdvancedAnnual report
「並びに健康予測アルゴリズム開発・疾病予測アプリ開発に33,114千円等の投資を行いました。」
健康予測・疾病予測に関する研究開発について、当連結会計年度に33,114千円の投資を実施した。 - FY2022First statedAnnual report
「From August 2022, through the joint research chair “Extending Healthy Life Expectancy” established at Hirosaki University, we will work with Hirosaki University and the Tokio Marine Group to develop and provide health prediction systems and severe disease risk prediction systems based on analysis of current conditions using health checkup data and claims data.」
Collaboration with Hirosaki University and the Tokio Marine Group to develop and provide health prediction and severe disease risk prediction systems is disclosed as a standalone theme for the first time.